CMS finalized its end-stage renal disease treatment options model and radiation oncology payment models Sept. 18.
Five things to know:.
Morgan Haefner –
Friday, September 18th, 2020
1. The end-stage renal illness treatment options design remains in reaction to an executive order signed by President Donald Trump that calls for increased usage of home dialysis and kidney transplants for Medicare clients with chronic kidney disease. It aims to enhance care quality and lower Medicare costs for members who require dialysis and kidney transplants..
2. CMS forecasts the model will impact about 30 percent of kidney care suppliers..
3. The brand-new design begins Jan. 1 and is predicted to save Medicare $23 million over 5 and a half years, according to CMS.
4. CMS likewise finalized its radiation oncology rodel, which aims to improve care outcomes for cancer clients who receive radiotherapy while lowering Medicare expenses.
5. The radiation oncology design features bundled payments that CMS said will incentivize the use of more medically and economical treatments. It begins Jan. 1, and is predicted to conserve Medicare $230 million over five years.
© Copyright ASC COMMUNICATIONS 2020.
© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
The end-stage kidney disease treatment choices model is in response to an executive order signed by President Donald Trump that calls for increased usage of house dialysis and kidney transplants for Medicare clients with chronic kidney illness. The radiation oncology design includes bundled payments that CMS said will incentivize the usage of more medically and cost-effective treatments. It begins Jan. 1, and is forecasted to save Medicare $230 million over 5 years.
More articles on healthcare financing:8 health systems with strong financesChicago healthcare facility beats claims of ghost payroll scheme10 ACOs with the most shared savings in 2019.